Cisplatin-ifosfamide as neoadjuvant chemotherapy in stage IIIB cervical uterine squamous-cell carcinoma
β Scribed by Pedro C. Lara; Jose L. Garcia-Puche; Vicente Pedraza
- Publisher
- Springer
- Year
- 1990
- Tongue
- English
- Weight
- 251 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Glutathione S-transferases (GSTs) are metabolic phase II enzymes that promote reactive metabolite elimination by conjugating them to glutathione (GSH). Because of their important role in xenobiotic metabolism and detoxification, they have been implicated in carcinogenesis processes, especially epith
## Abstract ## BACKGROUND The goal of the current study was to evaluate the efficacy and toxicity of paclitaxel, cisplatin (P), tegafur (T), and leucovorin (L) as a neoadjuvant chemotherapy (CT) for patients with advanced, unresectable squamous cell carcinoma of the head and neck. ## METHODS Fro
## BACKGROUND. The locoregional failure rate remains high in advanced cervical carcinoma. Chemotherapy (CT) was added to radiotherapy (RT) in order to increase disease control and to improve 5-year survival. ## METHODS. CT+RT included cisplatin administered 100 mg/mz, d.1 plus 5-flUOrOuracil 10